In the present study, we analysed the serum MMP-7 concentrations in three treatment cohorts (RNU, CTX and ICI) of UTUC patients and found significantly elevated pre-treatment MMP-7 levels in patients with lymph node or distant metastases. This evidence concerns the gene MMP7 and renal pelvis/ureter urothelial carcinoma.